ASX/SPL (ASX/SPL)

Australian Securities Exchange: ASX/SPL · AUD

A$0.43

-0.03 (-6.5%)· Recorded snapshot

Market cap	206.3M
Revenue (ttm)	12.7M
Net income (ttm)	-7.5M
EPS (ttm)	-A$0.02
Shares out	479.7M
Volume	1,186,114
Beta	0.72

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 12.7M
Net income (ttm): -7.5M
EPS (ttm): -A$0.02
Market cap: 206.3M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-45.6

P25 n/aP50 n/aP75 n/a

ROIC-26

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All ASX/SPL indicators

Market & fundamental data

Available fields

189

Groups with data

Currency

AUD

Showing 189 of 189 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	AUD
Country	Australia
Country code	AU
Earnings date	2026-11-16
Employees	50
Employees change	10
Employees growth	25%
Enterprise value	AUD 196M
Exchange	Australian Securities Exchange
Financial currency	AUD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	June
Founded	1997
Industry	Biotechnology
Is primary listing	Yes
ISIN number	AU000000SPL0
Last earnings date	2026-02-25
Last refreshed	2026-10-29
Market cap	AUD 206.3M
Next earnings date	2026-11-16
Price	AUD 0.43
Price currency	AUD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-29
Symbol	asx/SPL
Website	https://starpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-4.65%
EV/Sales	15.47x
FCF / EV yield	-1.78%
FCF yield	-1.7%
Industry forward P/E	28.82x
P/B ratio	14.97x
P/S ratio	16.28x
Price / tangible book value	14.97x
Sector forward P/E	34.02x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-58.93%
EBITDA margin	-56.65%
Gross margin	6.11%
Operating margin	-58.93%
Pretax margin	-58.93%
Profit margin	-58.93%
Profit per employee	AUD -149,300
Revenue per employee	AUD 253,360
ROA	-21%
ROA (5Y)	-16.71%
ROCE	-53.9%
ROE	-45.55%
ROE (5Y)	-36.14%
ROIC	-26%
SBC / revenue	17.71%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	1
Net income growth years	1
Revenue growth	116.55%
Revenue growth (Q)	-55.8%
Revenue growth (QoQ)	-86.44%
Revenue growth 10Y	10.5%
Revenue growth 3Y	42.88%
Revenue growth 5Y	29.43%
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	AUD -287,000
Depreciation and amortization	AUD 288,000
EBIT	AUD -7.5M
EBITDA	AUD -7.2M
EPS	AUD -0.02
FCF per share	AUD -0.01
Financing cash flow	AUD -876,000
Free cash flow	AUD -3.5M
Free cash flow minus SBC	AUD -5.7M
Gross profit	AUD 774,000
Investing cash flow	AUD -259,000
Net borrowing	AUD -876,000
Net cash flow	AUD -4.4M
Net income	AUD -7.5M
Operating cash flow minus SBC	AUD -5.5M
Operating income	AUD -7.5M
Revenue	AUD 12.7M
Stock-based compensation	AUD 2.2M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-0.31
Book value per share	AUD 0.03
Debt / equity	0.05
Long-term assets	AUD 1.4M
Long-term liabilities	AUD 75,000
Net cash (debt)	AUD 10.3M
Net cash / market cap	5%
Net cash growth	-20.74%
Net debt / equity	-0.75
Piotroski F-Score	3
Property, plant and equipment	AUD 1.4M
Shareholders' equity	AUD 13.8M
Tangible book value	AUD 13.8M
Tangible book value per share	AUD 0.03
Total assets	AUD 19M
Total cash	AUD 11M
Total debt	AUD 707,000
Total liabilities	AUD 5.2M
WACC	8.19%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.57
Current assets	AUD 17.6M
Current liabilities	AUD 5.2M
Current ratio	3.4
Inventory turnover	6.66
Net working capital	AUD 2.1M
Quick ratio	2.98
Working capital	AUD 12.4M
Working capital turnover	0.85

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.61%
Shareholder yield	-0.61%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-41.1%
10Y return CAGR	-4.91%
10Y total return	-39.54%
150-day SMA	AUD 0.70
15Y price change	-63.09%
15Y return CAGR	-6.27%
15Y total return	-62.11%
1D price change	-6.52%
1M price change	-47.56%
1M total return	-47.56%
1W price change	-8.51%
1W total return	-8.51%
1Y price change	28.36%
1Y return CAGR	31.78%
1Y total return	31.76%
20-day SMA	AUD 0.68
200-day SMA	AUD 0.63
20Y price change	-27.12%
20Y return CAGR	-1.44%
20Y total return	-25.19%
3M price change	-42.28%
3M total return	-42.28%
3Y price change	207.14%
3Y return CAGR	46.62%
3Y total return	215.28%
50-day SMA	AUD 0.73
50-day SMA vs 200-day SMA	50over200
52-week high	AUD 0.88
52-week high date	2026-09-30
52-week low	AUD 0.32
52-week low date	2025-12-22
5Y price change	-59.81%
5Y return CAGR	-16.23%
5Y total return	-58.75%
6M price change	-39.01%
6M total return	-37.39%
All-time high	AUD 2.52
All-time high date	2021-02-16
All-time low	AUD 0.08
All-time low date	2025-05-21
Average true range (ATR)	AUD 0.05
Average volume	2.8M
Beta (1Y)	2.15
Beta (2Y)	1.42
Beta (5Y)	0.72
Change from 52-week high	-50.86%
Change from 52-week low	34.38%
Change from all-time high	-82.94%
Change from all-time low	424.39%
Change from open	-6.52%
Day's gap	0%
Dollar volume	AUD 510,029
High price	AUD 0.48
Low price	AUD 0.43
Monthly RSI	49.14
Open price	AUD 0.46
Position in 52-week range	0%
Previous close	AUD 0.46
Price vs 150-day SMA	-38.58%
Price vs 20-day SMA	-36.55%
Price vs 200-day SMA	-31.85%
Price vs 50-day SMA	-41.06%
Relative volume	0.43
RSI	20.65
Sharpe ratio	0.6
Sharpe ratio (3Y)	0.79
Sharpe ratio (5Y)	0.11
Sortino ratio	0.93
Sortino ratio (3Y)	1.5
Sortino ratio (5Y)	0.26
Volume	1.2M
Weekly RSI	35.89
YTD price change	19.44%
YTD total return	22.61%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	331.2M
Shares change (QoQ)	0.39%
Shares change (YoY)	0.61%
Shares held by insiders	17.32%
Shares held by institutions	17.25%
Shares outstanding	479.7M

Deeper analysis on ASX/SPL

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ASX/SPL report

Is a complete ASX/SPL research report available?

No complete published report is available for asx/SPL (ASX/SPL) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ASX/SPL (ASX/SPL)

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/SPL

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/SPL indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ASX/SPL

Frequently asked questions